133 related articles for article (PubMed ID: 21349381)
1. [Epithelial ovarian cancer dysplasia: At last a "precancerous" lesion of the ovary!].
Sabourin JC
Ann Pathol; 2011 Feb; 31(1):2. PubMed ID: 21349381
[No Abstract] [Full Text] [Related]
2. [Ovarian epithelial dysplasia: Description of a dysplasia scoring scheme].
Chene G; Dauplat J; Raoelfils I; Bignon YJ; Cayre A; Jaffeux P; Aublet-Cuvelier B; Pomel C; Penault-Llorca F
Ann Pathol; 2011 Feb; 31(1):3-10. PubMed ID: 21349382
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer.
Dauplat J; Chene G; Pomel C; Dauplat MM; Le Bouëdec G; Mishellany F; Lagarde N; Bignon YJ; Jaffeux P; Aublet-Cuvelier B; Dechelotte P; Pouly JL; Penault-Llorca F
Eur J Cancer; 2009 Nov; 45(17):2977-83. PubMed ID: 19822418
[TBL] [Abstract][Full Text] [Related]
4. Differentiation and proliferation related proteins in the epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition.
McCluggage WG
Histopathology; 2004 Sep; 45(3):298-9. PubMed ID: 15330810
[No Abstract] [Full Text] [Related]
5. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881
[TBL] [Abstract][Full Text] [Related]
6. Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations.
Deligdisch L; Gil J; Kerner H; Wu HS; Beck D; Gershoni-Baruch R
Cancer; 1999 Oct; 86(8):1544-50. PubMed ID: 10526284
[TBL] [Abstract][Full Text] [Related]
7. Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity.
Nieto JJ; Crow J; Sundaresan M; Constantinovici N; Perrett CW; MacLean AB; Hardiman PJ
Gynecol Oncol; 2001 Aug; 82(2):344-9. PubMed ID: 11531291
[TBL] [Abstract][Full Text] [Related]
8. Hyperplastic and early neoplastic changes in the ovaries of mice after genic deletion of germ cells.
Murphy ED
J Natl Cancer Inst; 1972 May; 48(5):1283-95. PubMed ID: 4337905
[No Abstract] [Full Text] [Related]
9. Differences in symptoms between patients with benign and malignant ovarian neoplasms.
Attanucci CA; Ball HG; Zweizig SL; Chen AH
Am J Obstet Gynecol; 2004 May; 190(5):1435-7. PubMed ID: 15167861
[TBL] [Abstract][Full Text] [Related]
10. Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer.
Hermsen BB; von Mensdorff-Pouilly S; Berkhof J; van Diest PJ; Gille JJ; Menko FH; Blankenstein MA; Kenemans P; Verheijen RH
J Clin Oncol; 2007 Apr; 25(11):1383-9. PubMed ID: 17416858
[TBL] [Abstract][Full Text] [Related]
11. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.
Piek JM; van Diest PJ; Zweemer RP; Jansen JW; Poort-Keesom RJ; Menko FH; Gille JJ; Jongsma AP; Pals G; Kenemans P; Verheijen RH
J Pathol; 2001 Nov; 195(4):451-6. PubMed ID: 11745677
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma.
Seidman JD; Wang BG
Gynecol Oncol; 2007 Jul; 106(1):201-6. PubMed ID: 17477958
[TBL] [Abstract][Full Text] [Related]
13. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX
Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280
[TBL] [Abstract][Full Text] [Related]
14. Ovarian dysplasia. A study of identical twins.
Gusberg SB; Deligdisch L
Cancer; 1984 Jul; 54(1):1-4. PubMed ID: 6539159
[TBL] [Abstract][Full Text] [Related]
15. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies.
Salazar H; Godwin AK; Daly MB; Laub PB; Hogan WM; Rosenblum N; Boente MP; Lynch HT; Hamilton TC
J Natl Cancer Inst; 1996 Dec; 88(24):1810-20. PubMed ID: 8961970
[TBL] [Abstract][Full Text] [Related]
16. Expression of cell cycle regulatory proteins in ovaries prophylactically removed from Jewish Ashkenazi BRCA1 and BRCA2 mutation carriers: correlation with histopathology.
Kerner R; Sabo E; Gershoni-Baruch R; Beck D; Ben-Izhak O
Gynecol Oncol; 2005 Nov; 99(2):367-75. PubMed ID: 16051332
[TBL] [Abstract][Full Text] [Related]
17. Ovarian epithelial dysplasia after ovulation induction: time and dose effects.
Chene G; Penault-Llorca F; Le Bouëdec G; Mishellany F; Dauplat MM; Jaffeux P; Aublet-Cuvelier B; Pouly JL; Dechelotte P; Dauplat J
Hum Reprod; 2009 Jan; 24(1):132-8. PubMed ID: 18824470
[TBL] [Abstract][Full Text] [Related]
18. Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition.
Piek JM; Verheijen RH; Menko FH; Jongsma AP; Weegenaar J; Gille JJ; Pals G; Kenemans P; van Diest PJ
Histopathology; 2003 Jul; 43(1):26-32. PubMed ID: 12823709
[TBL] [Abstract][Full Text] [Related]
19. [Familial cancer of the ovary. A family with 6 index cases].
de Meeus JB; Bennouna C; Maréchaud M; Plocoste V; Magnin G
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):749-56. PubMed ID: 8308201
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
